Abstract: The present disclosure provides a method of treating cancer in a subject in need thereof comprising administering a checkpoint inhibitor to the subject, and administering a MALT-1 inhibitor according to an intermittent dosage regimen.
Type:
Application
Filed:
June 24, 2021
Publication date:
July 27, 2023
Applicants:
THE GENERAL HOSPITAL CORPORATION, MONOPTEROS THERAPEUTICS, INC.
Inventors:
Thorsten R. MEMPEL, Mauro DI PILATO, Ulrich H. VON ANDRIAN, Peter KELLER